T1	Participants 82 109	patients with schizophrenia
T2	Participants 403 480	Forty-seven patients with schizophrenia meeting criteria for deficit syndrome
T3	Participants 902 950	Thirty-nine patients completed the 8-week trial.
T4	Participants 951 1028	Seven dropouts occurred in the D-cycloserine group and 1 in the placebo group
